Skip to main content
13 August 2026
26 August 2025

Pfizer Accelerates Oncology Innovation Through Global 3SBio Partnership

Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the development, manufacturing and commercialization of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, currently undergoing several clinic…

25 August 2025

Kite to Acquire Interius BioTherapeutics for $350M

Kite, a Gilead Company , announced that it has entered into a definitive agreement to acquire Interius BioTherapeutics, a privately held biotechnology company developing in vivo CAR therapeutics, for $350 million. This acquisition complements Kite's expertise in cell therapy by incorporating Interius's integrating in…

20 August 2025

AbbVie Expands Portfolio with Capstan Therapeutics Acquisition

AbbVie announced that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition, Capstan is now a part of AbbVie. "With the acquisition now complete, we are excited to work together with the talented team at Capstan to advance our mission of transforming patient care," said Jona…

20 August 2025

XtalPi, Dong-A ST Join Forces for AI-Powered Drug Discovery

XtalPi announced that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases. This collaboration will be based on XtalPi's intelligent and automated drug discovery platform, which integrates artif…

13 August 2025

Bayer Partners with Kumquat to Advance Cancer Drug

Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company founded by pioneers of the KRAS pathway, announced that they have entered into an exclusive global license and collaboration to develop and commercialize Kumquat's KRAS G12D inhibitor. Under the agreement, Kumquat is responsible for the initiation an…

12 August 2025

Sartorius Invests in Nanotein for Next-Gen Immune Cell Solutions

Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, and Nanotein Technologies, a developer of next-generation immune cell activation reagents, have entered into a partnership. As part of the collaboration, Sartorius Stedim Biotech will invest up to 3 million US dollars in a minority sharehol…

12 August 2025

Kexing Biopharm Partners with IQVIA to Drive Global Drug Development

Kexing Biopharm has officially entered into a comprehensive strategic partnership with IQVIA, a global leader in clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. The partnership aims to accelerate the global clinical development, regulatory app…

07 August 2025

XtalPi and DoveTree Forge $5.99B Alliance to Drive AI-Led Therapeutics

XtalPi , a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced a transformative strategic collaboration with DoveTree Medicines, a biotechnology pioneer founded by renowned drug developer Dr. Gregory Verdine. The collaboration, worth up…

06 August 2025

Supreme Group Acquires Pivot Design to Expand Healthcare Marketing Capabilities

Supreme Group, a next-generation agency platform purpose-built for healthcare and life sciences marketing and communications, announced it has acquired Pivot Design, a globally recognized agency known for infusing health brands with humanity and bold storytelling. This latest milestone marks Supreme Group's ninth acqu…

06 August 2025

VERTEX and ADAMS Unite to Offer Full-Spectrum Healthcare Program Management

The VERTEX Companies, LLC, a global professional services firm delivering expert, forensic, construction project advisory, and management and regulatory consulting services, has acquired ADAMS Management Services Corporation, a nationally recognized leader in healthcare program and project management. This strategic a…

Page 29 of 36